Stacy Markison

Stacy Markison has held leadership positions in early pharmaceutical research and development over the past 15 years. She is currently the Senior Director of Pharmacology and Toxicology at Crinetics where she and her colleagues are progressing treatments for rare endocrine disorders and endocrine-related cancers. Stacy has more than a decade of chemical senses research experience within academia and industry. She received her Ph.D. from the University of Florida where her research focused on the role of the gustatory system in recovery from nutrient deficiencies. Additionally, she worked at Senomyx leading efforts to explore the role of taste receptors within the digestive tract. As the Director of Biology, she guided human salty taste receptor projects aimed at identifying salt taste enhancers. Stacy’s research background also includes the neurohormonal control of ingestive behavior as a post-doctoral fellow at the University of Pennsylvania, and the treatment of metabolic diseases such as obesity and cachexia at Neurocrine Biosciences. Stacy has over 40 publications and book chapters and has received external funding from NIH and the Michael J. Fox Foundation during the course of her career.